Abstract
Structural neuroimaging data have been used to compute an estimate of the biological age of the brain (brain-age) which has been associated with other biologically and behaviorally meaningful measures of brain development and aging. The ongoing research interest in brain-age has highlighted the need for robust and publicly available brain-age models pre-trained on data from large samples of healthy individuals. To address this need we have previously released a developmental brain-age model. Here we expand this work to develop, empirically validate, and disseminate a pre-trained brain-age model to cover most of the human lifespan. To achieve this, we selected the best-performing model after systematically examining the impact of seven site harmonization strategies, age range, and sample size on brain-age prediction in a discovery sample of brain morphometric measures from 35,683 healthy individuals (age range: 5–90 years; 53.59% female). The pre-trained models were tested for cross-dataset generalizability in an independent sample comprising 2101 healthy individuals (age range: 8–80 years; 55.35% female) and for longitudinal consistency in a further sample comprising 377 healthy individuals (age range: 9–25 years; 49.87% female). This empirical examination yielded the following findings: (1) the accuracy of age prediction from morphometry data was higher when no site harmonization was applied; (2) dividing the discovery sample into two age-bins (5–40 and 40–90 years) provided a better balance between model accuracy and explained age variance than other alternatives; (3) model accuracy for brain-age prediction plateaued at a sample size exceeding 1600 participants. These findings have been incorporated into CentileBrain (https://centilebrain.org/#/brainAGE2), an open-science, web-based platform for individualized neuroimaging metrics.
| Original language | English |
|---|---|
| Article number | e26768 |
| Number of pages | 14 |
| Journal | Human Brain Mapping |
| Volume | 45 |
| Issue number | 10 |
| DOIs | |
| Publication status | Published - 15 Jul 2024 |
Bibliographical note
Publisher Copyright:© 2024 The Author(s). Human Brain Mapping published by Wiley Periodicals LLC.
Funding
Avid Radiopharmaceuticals, Grant/Award Number: RF-2019-12370182; Bayer Oncology (Scientific Advisory Board); Eisai (ScientificAdvisory Board); Novo Nordisk (Scientific Advisory Board); Big Data to Knowledge (BD2K) Program, Grant/Award Number: U54EB020403; The ENIGMA World Aging Center, Grant/Award Number: R56 AG058854; The ENIGMA Sex Differences Initiative, Grant/Award Number: R01 MH116147; Marato TV3 Foundation, Grant/Award Number: 01/2010; Carlos III Health Institute, Grant/Award Number: PI040829; Knut and Alice Wallenberg (KAW) Foundation; Donders Centre for Cognitive Neuroimaging; Human Genetics and Cognitive Neuroscience departments of the Radboud university medical centre; Max Planck Institute for Psycholinguistics; Biobanking and Biomolecular Resources Research Infrastructure (Netherlands) (BBMRI-NL); Hersenstichting Nederland; Netherlands Organization for Scientific Research (NWO),i.e., the NWO Brain & Cognition Excellence Program, Grant/Award Number: 433-09-229; Vici Innovation Program, Grant/Award Numbers: 016-130-669, 91619115; European Community's Seventh Framework Programme (FP7/2007–2013), Grant/Award Numbers: 602805, 603016, 602450, 278948; NIH, Grant/Award Numbers: R01MH62873, P30AG010133, R01 AG019771, R01 CA129769, P30 AG072976, R01 AG057739, U01AG024904, R01 LM013463, R01 AG068193, T32 AG071444, U01 AG068057, U01AG072177, RC2DA029475; NWO Large Investment grant, Grant/Award Number: 1750102007010; ZonMW grant, Grant/Award Number: 60-60600-97-193; NWO, Grant/Award Numbers: 056-13-015,433-09-242; Radboud University Nijmegen Medical Center; University Medical Center Groningen and Accare; Vrije Universiteit Amsterdam; EU-AIMs programme; AIMS-2-TRIALS programme; Innovative Medicines Initiative Joint Undertaking grant, Grant/Award Numbers: 115300, 777394; European Federation of Pharmaceutical Industries and Associations (EFPIA); AUTISMSPEAKS; Autistica; SFARI; Horizon2020 supported programme CANDY grant, Grant/Award Number: 847818; European Community's Horizon 2020 Programme (H2020/2014–2020), Grant/Award Numbers: 643051, 667302, 847879; Netherlands Organization for Scientific Research (NWO) for the GUTS project, Grant/Award Number: 024.005.011; National Institute for Health Research (NIHR) Maudsley Biomedical Research Centre at South London and Maudsley NHS Foundation Trust; King's College London; German Research Foundation, Grant/Award Numbers: WA 1539/11-1, SFB-TRR58; National Institute of Mental Health (NIMH), Grant/Award Number: T32MH122394; Siemens Medical Solutions; American Epilepsy Society; Epilepsy Foundation; Epilepsy Therapy Project; Fight Against Childhood Epilepsy and Seizures (F.A.C.E.S.); Parents Against Childhood Epilepsy (P.A.C.E.); GE/NFL Head Health Challenge I; Indiana State Department of Health Spina lCord and Brain Injury Fund Research Grant Program; Project Development Team within the ICTSI NIH/NCRR, Grant/Award Number: RR025761; Italian ministry of health ricerca corrente 23; European Research Council, Grant/Award Number: ERC CoG PROSOCIAL 681632; Research Council of Norway, Grant/Award Numbers: 223273, 288083, 323951; South-Eastern Norway Regional Health Authority, Grant/Award Numbers: 2019069, 2021070, 2023012, 500189; National Health & Medical Research Council (NHMRC) Program, Grant/Award Numbers: ID350833, ID568969, APP1093083; Australian Research Council (ARC) Strategic Award Grant of the Ageing Well, Ageing Productively Program, Grant/Award Number: 401162; NHMRC Project (seed), Grant/Award Numbers: 1024224, 1025243; NHMRC Project, Grant/Award Numbers: 1045325, 1085606, 1064643, 1024570; NHMRC Program grants, Grant/Award Numbers: 568969, 1093083, R01AG059874,R01MH117601, R01NS107513, R01AG058854, P41EB015922; NHMRC Investigator Grant, Grant/Award Number: GNT2009771; Department of Energy, Grant/Award Number: DEFG02-99ER62764; Canadian Institutes of Health Research, Grant/Award Number: 126053; National Institute on Drug Abuse and the Eunice Kennedy Shriver National Institute of Child Health & Human Development; Health Research Board Ireland; NIMH, Grant/Award Number: 1R01MH085667-01A1; JohnS. Dunn Foundation (Houston, Texas); Pat Rutherford Chair in Psychiatry (UTHealth Houston); Dutch Research Council, Grant/Award Number: NWO 51.02.61; NWO-NIHC Programs of excellence, Grant/Award Number: 433-09-220
| Funders | Funder number |
|---|---|
| Avid Radiopharmaceuticals | RF-2019-12370182 |
| Bayer Oncology | |
| Eisai Limited | |
| Novo Nordisk A/S | |
| Big Data to Knowledge Program | U54EB020403 |
| ENIGMA | R56 AG058854, R01 MH116147 |
| Marato TV3 Foundation | 01/2010 |
| Instituto de Salud Carlos III | PI040829 |
| Knut and Alice Wallenberg Foundation | |
| Radboud University Medical Center | |
| Max Planck Institute for Psycholinguistics | |
| Biobanking and Biomolecular Resources Research Infrastructure | |
| Hersenstichting | |
| Nederlandse Organisatie voor Wetenschappelijk Onderzoek | 433-09-229, 016-130-669, 91619115, 1750102007010, 056-13-015, 433-09-242, 024.005.011, 433-09-220, 51.02.61 |
| European Community's Seventh Framework Programme | 602805 , 603016, 602450, 278948 |
| National Institutes of Health | R01MH62873, P30AG010133, R01 AG019771, R01 CA129769, P30 AG072976, R01 AG057739, U01AG024904, R01 LM013463, R01 AG068193, T32 AG071444, U01 AG068057, U01AG072177, RC2DA029475, RR025761 |
| ZonMw | 60-60600-97-193 |
| University Medical Center Groningen | |
| Vrije Universiteit Amsterdam | |
| EU-AIMs programme | |
| AIMS-2-TRIALS programme | |
| Innovative Medicines Initiatives | 1153001, 777394 |
| European Federation of Pharmaceutical Industries and Associations | |
| Autism Speaks Inc | |
| Autistica | |
| European Community's Horizon 2020 Programme | 847818, 643051, 667302, 847879 |
| South London and Maudsley NHS Foundation Trust | |
| Oxford National Institute for Health and Research (NIHR) | |
| Kings College London, University of London | |
| German Research Foundation | WA 1539/11-1, SFB-TRR58 |
| National Institute of Mental Health | T32MH122394, 1R01MH085667-01A1 |
| Siemens Medical Solutions | |
| American Epilepsy Society | |
| Epilepsy Foundation | |
| Epilepsy Therapy Project | |
| Fight Against Childhood Epilepsy and Seizures | |
| Parents Against Childhood Epilepsy | |
| GE/NFL Head Health Challenge I | |
| Indiana State Department of Health Spinal Cord and Brain Injury Fund Research Grant Program | |
| Italian Ministry of Health Ricerca Corrente 23 | |
| European Research Council | CoG PROSOCIAL681632 |
| Research Council of Norway | 223273, 288083, 323951 |
| South-Eastern Norway Regional Health Authority | 2019069, 2021070, 2023012, 500189 |
| National Health and Medical Research Council | ID350833, ID568969, APP1093083, 1024224, 1025243, 1045325, 1085606, 1064643, 1024570, 568969, 1093083, R01AG059874, R01MH117601, R01NS107513, R01AG058854, P41EB015922, GNT2009771 |
| Australian Research Council | 401162 |
| United States Department of Energy | DEFG02-99ER62764 |
| Canadian Institutes of Health Research | 126053 |
| National Institute on Drug Abuse | |
| Eunice Kennedy Shriver National Institute of Child Health & Human Development | |
| Health Research Board Ireland | |
| John S. Dunn Foundation | |
| Pat Rutherford Chair in Psychiatry |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Benchmarking
- Brain aging
- brainAGE
Fingerprint
Dive into the research topics of 'Brain-age prediction: Systematic evaluation of site effects, and sample age range and size'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver